PAK2 and esophageal squamous cell carcinoma: Potential druggable targets include USP13, LAMP3, BRD9, TNK2, PAK2, and PRKDC which are overexpressed in ESCC based on RNA-Seq datasets from TCGA (Supplementary Figure 11) (26).